Stockwinners Market Radar for July 20, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:03 EDT Helbiz CEO buys $204K in common stock - In a regulatory filing, Helbiz disclosed that its CEO Salvatore Palella bought 327K shares of common stock in a total transaction size of $204K.

18:57 EDT 'Minecraft' developer says NFTs, blockchain tech not allowed in the game - Mojang, the Microsoft-owned (MSFT) studio behind the "Minecraft" series of games, released a blog post sharing its view that integrations of non-fungible tokens, or NFTs, with "Minecraft" are "generally not something we will support or allow." "To ensure that Minecraft players have a safe and inclusive experience, blockchain technologies are not permitted to be integrated inside our client and server applications, nor may Minecraft in-game content such as worlds, skins, persona items, or other mods, be utilized by blockchain technology to create a scarce digital asset," the company said. "As such, to ensure that Minecraft players have a safe and inclusive experience, blockchain technologies are not permitted to be integrated inside our Minecraft client and server applications nor may they be utilized to create NFTs associated with any in-game content, including worlds, skins, persona items, or other mods," the developer continued. "We will also be paying close attention to how blockchain technology evolves over time to ensure that the above principles are withheld and determine whether it will allow for more secure experiences or other practical and inclusive applications in gaming. However, we have no plans of implementing blockchain technology into Minecraft right now." The news comes as game companies such as GameStop (GME), Epic Games, Ubisoft (UBSFY), and Square Enix (SQNXF) have announced forays into or explorations of NFTs. Investors in Epic include Tencent (TCEHY), KKR (KKR), Disney (DIS), and Sony (SONY). Reference Link

18:40 EDT Regions Financial raises quarterly dividend to 20c from 17c per share - The dividend is payable on Oct. 3, 2022 to stockholders of record at the close of business on Sept. 2, 2022.

18:25 EDT ON Semiconductor CEO sells $1.1M in common stock - In a regulatory filing, ON Semiconductor disclosed that its CEO Hassane El-Khoury sold 20K shares of common stock in a total transaction size of $1.1M.

18:00 EDT Roblox rolls out advancements to material system, enhancing visual quality - Josh Anon, Roblox Product Director blogged earlier: "Today, we're excited to announce that we've officially rolled out a number of advancements to our material system, moving them out of beta and into the hands of our broader community. With this release, we've enhanced the visual quality of our entire existing library of materials, which includes brick, glass, metal, and many other common materials, to make them look and feel even more realistic than before. These material upgrades will be the default option for all new experiences moving forward. Creators can upgrade their existing experiences as they see fit (read our documentation here to learn how), and our classic materials remain available if developers wish to continue using them. In addition, creators now have access to a new, user-friendly Material Manager tool in Roblox Studio allowing them to make custom variations of our base materials to better suit their aesthetic vision. Now, before we dive any deeper into the details, let's first take a step back and understand what materials are and what makes those on Roblox so unique." Reference Link

17:47 EDT Tesla CEO says bitcoin conversion intended to 'maximize cash position' - CEO Elon Musk clarifies: "It should be mentioned that the reason we sold a bunch of our Bitcoin holdings was that we were uncertain as to when the COVID lockdowns in China would alleviate. So it was important for us to maximize our cash position, given the uncertainty of the COVID lockdowns in China. We are certainly open to increasing our Bitcoin holdings in future, so this should not be taken as some verdict on Bitcoin. It's just that we were concerned about overall liquidity for the company, given COVID shutdowns in China." Comments taken from Q2 earnings conference call.

17:41 EDT Tesla says still expecting to be production with Cybertruck in middle of 2023

17:32 EDT Discover reports Q2 credit card net charge-off rate 2.01% - In Q2: The total net charge-off rate of 1.80% was 32 basis points lower versus the prior year period reflecting strong credit performance across the portfolio. The credit card net charge-off rate was 2.01%, down 44 basis points from the prior year period and up 17 basis points from the prior quarter. The 30+ day delinquency rate for credit card loans was 1.76%, up 33 basis points year-over-year.

17:30 EDT Discover reports Q2 total net charge-off rate 1.80% vs. 2.12% a year ago

17:15 EDT Community Bank System raises quarterly dividend by 2.3% to 44c per share - The dividend will be payable on October 10, 2022 to shareholders of record as of September 15, 2022.

17:05 EDT Blue Foundry Bancorp announces share repurchase program - Blue Foundry Bancorp announced that it has adopted a program to repurchase up to 2,852,250 shares of its common stock, which is approximately 10% of its outstanding common stock. This is the company's first stock repurchase program since completing its mutual-to-stock conversion and related stock offering in July 2021.

17:01 EDT Shift4 Payments names Samantha Weeks chief transformation officer - Shift4 announced the appointment of Samantha Weeks, PhD, to the position of Chief Transformation Officer. Weeks previously served as the company's Vice President of Transformation. "Samantha has already proven to be a great asset to Shift4 and we couldn't be more excited to welcome her into this expanded role," said Jared Isaacman, CEO. "Prior to her time at Shift4 I had the privilege of working with her in her capacity as the Air Force's Adversary Tactics Group Commander during my time building Draken International and couldn't think of a more qualified leader to help drive our never-ending pursuit of excellence at Shift4."

16:51 EDT Facebook Gaming introduces new 'Clips to Reels' feature for gamers - Facebook Gaming said in an earlier blog post: "Short form video has been increasing in popularity as an important way for creators to communicate with and grow their audience. One of the best ways to attract new viewers across Facebook is with Reels and now, creating 60-second Reels from existing Facebook Gaming content is about to get a whole lot easier. In June, we announced Clips to Reels, a new feature for gaming video creators on Facebook to convert live gameplay clips into Reels, was starting to roll out. Now, we're excited to share it is available to all partners and Level Up Creators. With these editing tools we're empowering creators with easy-to-use tools to let them transform existing live video clips into Reels. Creators can now easily cut clips of their favorite gameplay moments down to a vertical-friendly, 60-second format, with dual views for both gameplay and creator cam. The new Clips to Reels feature will allow creators to format and share highlights from Clips and VODs from within their Creator Studio Clips Library with a streamlined process." Reference Link

16:36 EDT United Airlines reports Q2 capacity down 15% vs. Q2 of 2019 - Reported Q2 TRASM of up 24% vs. Q2 of 2019, Cost Per Available Seat Mile up 32%, and CASM-ex of up 17% vs. Q2 of 2019.

16:32 EDT Steel Dynamics says 'Customer order entry activity continues to be healthy' - "Customer order entry activity continues to be healthy across all of our businesses, conflicting with the more pessimistic emotion in the marketplace," said CEO Millett. "Despite softening flat roll steel pricing, our steel order activity remains solid from the automotive, construction, and industrial sectors, with energy continuing to improve. Our steel fabrication operations order backlog remains at near-record volumes and forward pricing levels. This combined with continued healthy order activity and broad customer optimism, supports strong overall demand dynamics for the construction industry. "Operations continue to ramp up at our Sinton Flat Roll Steel Mill, and the team has already achieved run rates of 80 percent through the hot side. However, they have been challenged with unexpected power and equipment issues that have impacted their operating time in July. The team expects to realize meaningful improvement for the remainder of the year. We are investing approximately $500 million to build four additional value-added flat roll steel coating lines comprised of two paint lines and two galvanizing lines with Galvalume(R) coating capability, a set of which will be located onsite at our new Texas steel mill, providing Sinton with the same diversification and higher-margin product capabilities as our two existing flat roll steel divisions. The other two lines will be placed at our Heartland Flat Roll Division located in Terre Haute, Indiana to support growing coated flat roll steel demand in the region and to further increase the diversification and cash generation capacity of our existing Midwest operations. Based on current plans, we believe these four lines will begin operating in the second half of 2023. "We are excited about our recent partnership with Aymium," said Millett. "We believe this strategic joint venture will cost-effectively reduce our greenhouse gas emissions, which are already materially lower than our global steel competitors. We also believe Aymium's process can provide a renewable carbon alternative to fossil fuel for Iron Dynamics, our proprietary ironmaking operations. We have successfully trialed Aymium's biocarbon product in our steel operations, and conservatively estimate this first facility will reduce our Scope 1 steelmaking greenhouse gas emission intensity between 20 and 25 percent, with potential upside through the use of the facility's biogas. Our commitment to all aspects of sustainability is embedded in our founding principles. This investment represents a significant step forward on our path to carbon neutrality, and our continued commitment to reduce our environmental footprint." "We believe there are strong drivers for our continued growth and remain in a position of strength. Our recently announced planned investment in a new state-of-the-art low-carbon aluminum flat rolled mill continues our strategic growth, is aligned with our core steelmaking and recycling platforms, benefits many of our existing customers, and provides for future value creation. Our customers and our people are incredibly excited for this growth opportunity. Our commitment is to the health and safety of our teams, families, and communities, while meeting the growing needs of our customers. Our culture and business model continue to positively differentiate our performance from the industry. We are well-positioned for sustainable long-term growth and value creation," concluded Millett.

16:30 EDT Geospace secures long-term ocean bottom node rental contract - Geospace Technologies announced an extended duration rental contract with SAExploration, an international marine geophysical services provider who will rent OBX-750E seabed ocean bottom wireless seismic data acquisition nodes. Based on current contract terms, the value of the agreement is estimated at $12M. "Following our recent good news of a separate $4M OBX rental contract, we're pleased to announce this sizeable, long-term contract with another trusted customer," said Walter R. Wheeler, President and CEO, Geospace Technologies. "We're realizing the benefit of our earlier investments to build and maintain a sizable fleet of seabed seismic nodes. Combined with our recently announced OBX rentals, the minimum value from OBX product rental contracts executed during the fiscal year exceed $25M. Additionally, our shallow water units are nearly at pre-pandemic utilization levels. Sales and rentals of our OBX product line have been a reliable revenue workhorse for the company and we are encouraged by the current resurgence."

16:20 EDT Tesla up 2% to $758.76 in after-hours trading following earnings beat - Shares of Tesla are up $16.26, or 2%, to $758.76 in after-hours trading.

16:19 EDT Stanley Black & Decker raises quarterly dividend to 80 from 79c per share - The dividend is payable on Tuesday, September 20 to shareholders of record as of the close of business on Tuesday, September 6.

16:17 EDT Tesla says converted about 75% of Bitcoin purchases into fiat as of end of Q2 - Tesla said in its quarterly letter: "Quarter-end cash, cash equivalents and short-term marketable securities increased sequentially by $902M to $18.9B in Q2, driven mainly by free cash flow of $621M, partially offset by debt repayments of $402M. As of the end of Q2, we have converted approximately 75% of our Bitcoin purchases into fiat currency. Conversions in Q2 added $936M of cash to our balance sheet."

16:17 EDT Associated Capital reports preliminary Q2 book value of $40.20-$40.40 per share - Associated Capital Group announced a range of its second quarter preliminary book value of $40.20 to $40.40 per share. This compares to $41.72 at March 31, 2022, $42.48 per share at December 31, 2021 and $42.21 at June 30, 2021. Assets under management were $1.80B at June 30, 2022 as compared to $1.61B at June 30, 2021. Associated Capital will be issuing further details on its financial results in early August.

16:16 EDT HilleVax announces results of 5 year immunogenicity follow-up trial of HIL-214 - HilleVax announced results from NOR-213, a Phase 2 long-term immunogenicity follow-up clinical trial of adults and older adults who previously received HIL-214, the company's investigational virus-like particle based vaccine for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.NOR-213 included 528 adult and older adult subjects that were enrolled following participation in prior clinical studies of HIL-214, including NOR-107, NOR-204, and NOR-210. The subjects received either one or two doses of HIL-214 with or without the adjuvant monophosphoryl lipid A .Among all dose regimens of HIL-214, GI.1-specific and GII.4-specific HBGA-blocking and pan-Ig responses to vaccination persisted to year 5 of the study and, at year 5, results were similar to those previously reported at year 3. These results further support a single dose of HIL-214 without MPL as the intended regimen for future development in adults and older adults. No adverse events were deemed related to HIL-214, and no new safety risks were identified during the study.The company anticipates presenting detailed data from the NOR-213 clinical trial at a future medical meeting. "We believe the data from this 5-year clinical study are very encouraging for the long-term immunogenicity and safety profile of HIL-214," said Astrid Borkowski, MD, PhD, Chief Medical Officer of HilleVax. "We look forward to the continued development of HIL-214 across the age spectrum, including our ongoing Phase 2b study in infants and future clinical studies in adults and older adults."

16:12 EDT Alcoa authorizes additional $500M in share repurchases - "As we progress into the remainder of this volatile year, we remain focused on our strategic priorities and our vision to reinvent the aluminum industry for a sustainable future," CEO Roy Harvey said.

16:10 EDT Assembly Biosciences CMO Michele Anderson, CFO Michael Samar to depart - Luisa Stamm, the current Assembly Bio chief medical officer, will leave the company at the end of this month. Michele Anderson, SVP of development operations at Assembly Bio, has been appointed as chief development officer effective August 1 and will assume responsibility for the company's development organization. Additionally, Michael Samar, currently the CFO, will leave the organization effective August 12. Jason Okazaki, Assembly Bio's current chief operating officer, will oversee all general and administrative functions, including finance. Due to these increased departmental responsibilities, Okazaki has been appointed as president and chief operating officer effective August 1. John McHutchison will continue as chief executive officer at Assembly Bio. The reprioritization and restructuring activities are expected to extend Assembly Bio's estimated cash runway into the first half of 2024 after incurring a one-time charge for severance and other reorganization costs.

16:09 EDT Tesla sees sufficient liquidity to fund product roadmap - Tesla said in its quarterly update letter: "We plan to grow our manufacturing capacity as quickly as possible. Over a multi-year horizon, we expect to achieve 50% average annual growth in vehicle deliveries. The rate of growth will depend on our equipment capacity, factory uptime, operational efficiency and the capacity and stability of the supply chain. We have sufficient liquidity to fund our product roadmap, long-term capacity expansion plans and other expenses. While we continue to execute on innovations to reduce the cost of manufacturing and operations, over time, we expect our hardware-related profits to be accompanied with an acceleration of software-related profits. The pace of production ramps in Austin and Berlin-Brandenburg will be influenced by the successful introduction of many new product and manufacturing technologies in new locations and ongoing supply chain related challenges. Factory ramps take time, and Gigafactory Austin and Gigafactory Berlin-Brandenburg will be no different. We are making progress on the industrialization of Cybertruck, which is currently planned for Austin production subsequent to Model Y ramp."

16:09 EDT Assembly Biosciences to discontinue vebicorvir development, reduce workforce - Assembly Biosciences announced that it is discontinuing further development of its first-generation core inhibitor, vebicorvir, or VBR, as it prioritizes clinical development of its next-generation core inhibitors, ABI-H3733 and ABI-4334, and advances its research pipeline. Assembly Bio will restructure the organization and reduce its workforce to align with these strategic goals. Assembly Biosciences will discontinue clinical development of its first-generation investigational core inhibitor, VBR, based on review of interim on-treatment efficacy from the two ongoing VBR triple combination studies. The data indicate that the triple combinations do not show a benefit in multiple key viral parameters compared to the dual combinations without VBR in either study. As a result of these data, Study 203, an open-label, Phase 2 study evaluating the triple combination of VBR + nucleos(t)ide analogue reverse transcriptase inhibitors+ interferon versus the dual combinations of VBR + NrtI and NrtI + PEG-IFNalpha, will conclude immediately. No additional clinical studies of VBR are currently planned. Assembly Bio will align the organization to reflect its refocused pipeline. The company workforce will be reduced by approximately 30%, to approximately 70 full-time employees, to support clinical development of 3733 and 4334 and the company's novel research pipeline, and to optimize manufacturing of all candidates.

16:07 EDT Kinder Morgan approves cash dividend of 27.75c per share for Q2 - Kinder Morgan's board of directors today approved a cash dividend of 27.75c per share for the second quarter, payable on August 15, 2022, to stockholders of record as of the close of business on August 1, 2022. This dividend is a 3% increase over the second quarter of 2021.

16:07 EDT Ford to share update on Ford+ plan Thursday - Ford Motor Company on Thursday will share an update on the Ford+ plan to "lead the electric vehicle revolution." Ford will host a conference call for members of the media and investment community at 8 a.m. ET. Key Ford executives will provide details on how the company is building out its industrial system to reach a global production run rate of 600,000 EVs, growing to more than 2 million EV annual global run rate by 2026. A Q&A session will follow the presentation.

16:02 EDT Exicure regains compliance with Nasdaq minimum bid price requirement - Exicure "announced that on July 19, 2022, it received a letter from the Office of General Counsel of The Nasdaq Stock Market LLC informing it that Nasdaq has confirmed that the Company has regained compliance with the $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5450(a)(1) and that the Company is in compliance with all applicable listing standards."

15:12 EDT New Relic trading resumes

15:02 EDT Mattel announces multi-year agreement to produce SpaceX toys and collectibles - Mattel announced that it has entered into a multi-year agreement with SpaceX to create and market toys and collectibles. "In 2023, Mattel will begin releasing SpaceX-inspired toys under its iconic Matchbox brand. Simultaneously, astro-inspired collectibles will start to debut on Mattel Creations, Mattel's collaboration and direct-to-consumer platform," Mattel stated. Nick Karamanos, SVP Entertainment Partnerships at Mattel, added, "As space exploration advances more quickly than ever before, we are thrilled to work with SpaceX and help spark limitless play patterns for the space explorer in every kid."

13:55 EDT DoorDash to roll out new safety features for alcohol delivery in U.S. - DoorDash announced it is rolling out new safety features for alcohol delivery in the United States...The company added, in an earlier blog posting: "Since expanding alcohol delivery last year, DoorDash has seen tremendous demand from consumers, merchants and Dashers. By facilitating alcohol delivery, DoorDash helps merchants grow their businesses, enables customers to purchase alcohol safely and conveniently from home, and provides Dashers with additional earning opportunities. DoorDash estimates that adding alcohol may increase restaurants' and grocers' average customer order values by up to 30% and convenience stores by over 50%. In Q4 2021, U.S. Dashers earned, on average, almost 30% more on deliveries with alcohol than on non-alcohol deliveries..."At DoorDash, safety is a top priority and our goal is to deliver alcohol in the safest and most responsible way possible," said Erik Ragotte, DoorDash's General Manager of Alcohol. "With today's announcement of two-step or dual ID verification, we're setting a new industry standard for responsible alcohol delivery. The new safety measures will help ensure alcohol is delivered to people over the age of 21. We will continue to innovate and find even more ways to promote responsible alcohol delivery." Reference Link

13:42 EDT J.B. Hunt names Shelley Simpson president - J.B. Hunt Transport Services announced the appointment of Shelley Simpson as president of the company. The Board of Directors elected Shelley Simpson as company president effective August 1, 2022. Over Simpson's 28-year career at J.B. Hunt, she has served 15 years in executive leadership roles, most recently as chief commercial officer and executive vice president of people and human resources, in addition to leading International Services and Corporate Marketing. John N. Roberts, III, will remain chief executive officer and a member of the J.B. Hunt Board of Directors, a new management structure for the company. "Over her tenure at J.B. Hunt, Shelley has worn multiple hats across our business, bringing a data-driven, experienced-based approach to every area she has led," said Roberts. "If you look at the most disruptive areas of our company, from new technologies to global commercialization to investments in our people, Shelley's innovative leadership has always guided us toward positive results."

13:01 EDT Yellow Corp signs agreement with U.S. Army PaYS program - Yellow Corporation entered into a memorandum of agreement with the U.S. Army Partnership for Your Success program, demonstrating the Company's commitment to helping ensure veterans have successful careers upon leaving service. The PaYS Program is a strategic partnership between the U.S. Army and a cross section of corporations, companies and public sector agencies. The program provides America's Soldiers with an opportunity to serve their country while they prepare for their future.

12:32 EDT Algoma Steel reaches tentative agreement with USW Local 2724 - Algoma Steel Group announced that the Company has reached a tentative agreement for a new labour contract with United Steelworkers Local 2724, the union representing its technical, professional and front-line supervisory employees. The current collective agreement expires July 31, 2022. Ratification votes are scheduled for July 21st through July 25th, 2022. The Company will not be releasing details of the tentative agreement until after the Union has held its information meetings. Discussions are ongoing between the Company and the hourly employees represented by USW Local 2251, and the Company looks forward to reaching an agreement before the contract expires on July 31, 2022, ensuring the continuation of the Company's forward momentum.

12:06 EDT Valneva says EC to order 1.25M doses of VLA2001 vaccine in 2022 - Valneva announces that the European Commission has approved an amendment to the Advance Purchase Agreement it signed in November 2021 for Valneva's inactivated whole-virus COVID-19 vaccine, VLA2001. "The amendment will be signed after a mandatory five-day period during which Member States can opt out. Under this amendment, the Member States' purchases will consist of 1.25 million doses of VLA2001 in 2022, with the option to purchase an equivalent quantity later this year for delivery in 2022. This amendment follows remediation discussions based on the EC's notice of intent to terminate the initial APA for VLA2001 doses in 2022 and optional doses for 2023. The first vaccine doses will be delivered to participating EU Member States - Germany, Austria, Denmark, Finland and Bulgaria - in the coming weeks. Valneva will retain inventory for potential additional supply to these EU Member States should demand increase and, in parallel, will aim to deploy approximately eight to ten million doses of remaining inventory into international markets. Given that VLA2001's shelf life is expected to reach up to 24 months over time, the Company will aim to deploy these doses in the next six to twelve months," the company stated.

12:00 EDT Forestar Group falls -11.6% - Forestar Group is down -11.6%, or -$1.83 to $14.01.

12:00 EDT Carvana rises 14.6% - Carvana is up 14.6%, or $3.34 to $26.19.

12:00 EDT Silvergate Capital rises 15.0% - Silvergate Capital is up 15.0%, or $11.96 to $91.56.

11:37 EDT ABB to spin off turbocharging division, list on Swiss Exchange - ABB announces its intention to spin off Accelleron, formerly ABB Turbocharging, its turbocharging division, by way of a dividend in kind of Accelleron Industries shares to ABB's shareholders. Accelleron's listing on SIX Swiss Exchange in Zurich is planned for October 3, and is subject to, among others, approval by ABB's shareholders at a general meeting scheduled for September 7. "The proposed spin-off of Accelleron represents a unique opportunity for both companies, allowing them to focus on their respective core strategies and create long-term value for their stakeholders. ABB's shareholders will be able to realize the full value of Accelleron, while ABB continues to simplify its portfolio and focus on the megatrends of electrification and automation. Accelleron will be able to concentrate exclusively on reaching its full potential in the large engine industry where the company is known as the market leader in heavy-duty turbocharging, with a compelling growth profile, high cash generation and an attractive expected dividend policy," the company said in a statement. In 2021, Accelleron generated revenues of $756M with an operating margin of 25%. ABB has retained Credit Suisse and Goldman Sachs International as exclusive financial advisors on the transaction. Credit Suisse will be acting as listing agent.

11:34 EDT General Dynamics Mission Systems awarded $272.9M contract - General Dynamics Mission Systems announced it was awarded a U.S. Navy contract to support development, production and installation of fire control systems for the Columbia- and Dreadnought-classes of ballistic missile submarines. The contract as awarded has a value of $272.9 million over the next six years. This contract is the second for General Dynamics Mission Systems and is comprised of development, production and installation support for U.S. and U.K. submarine strategic weapons systems and subsystems. It will also support strategic weapons systems upgrades on currently fielded U.S. and U.K. strategic ballistic missile submarines. Work will primarily be performed in Pittsfield, Massachusetts, and is expected to be complete by July 2028.

11:22 EDT Soligenix announces results of Phase 3 FLASH study of HyBryte - Soligenix announced that the results of its successful Phase 3 FLASH study evaluating HyBryte for the treatment of cutaneous T-cell lymphoma has been published in the Journal of the American Medical Association Dermatology. The published findings demonstrate that HyBryte treatment statistically significantly reduced lesion size, with the treatment response further improving over successive 6-week treatment cycles. The primary endpoint evaluated the CAILS score of three treated index lesions and success was defined as greater than or equal to50% reduction in CAILS score relative to baseline. Lesion response continuously improved with treatment duration. After the first 6-week treatment window, 16% of patients had a response. This response rate continued to significantly increase to 49% through 18 weeks of treatment. Throughout the study, HyBryte was safe and well-tolerated. Importantly, HyBryte was observed to perform similarly against both patch and thicker plaque lesions characteristic of CTCL.

11:12 EDT Strategic Capital Advisers to join Focus partner firm Transform Wealth - Focus Financial Partner announced that it has entered into a definitive agreement under which Strategic Capital Advisers, an SEC registered investment adviser located in Denver, Colorado, will join Focus partner firm Transform Wealth. This transaction is expected to close in the second half of 2022, subject to customary closing conditions. Founded in 1994, SCA provides fee-only investment advisory services to individuals and institutions, including retirement plans. SCA and its principals, John Hancock and Jonathan Ahalt, have built a strong reputation in the greater Colorado area for helping address complex client situations and providing an excellent client experience.

11:08 EDT Corteva, 2Blades reach collaboration milestone for ASR resistance - 2Blades and Corteva Agriscience announced they have reached a milestone in their collaboration to develop a transgene for Asian Soybean Rust resistance with successful field trials of Latin American soybean varieties containing the new ASR transgene. This achievement marks an important point in the research collaboration between the two organizations, which seeks to develop durable resistance and minimize grower losses due to the plant pathogen. Endemic to most soybean-producing regions of the globe, ASR can cause yield loss ranging from 10-80% in countries where it is established, carrying significant risk for farmers and agricultural systems. Soybeans in Latin America are particularly vulnerable to this fungal disease due to mild winter conditions, which allow the fungus to survive year-round. The transgenic trait in development by 2Blades and Corteva will provide an additional disease management tool for farmers in the region, increasing disease resistance durability and options for integrated disease management strategies.

11:05 EDT Alignment Health Plan plans to expand into three Nevada counties - Alignment Health Plan plans to expand into three Nevada counties - Carson City, the state's capital, and neighboring Douglas and Storey counties - and introduce its preferred provider organization plans for the first time to the Silver State, pending regulatory approval from the Centers for Medicare & Medicaid Services. If approved, the company's Medicare Advantage prescription drug plans would be available in six Nevada counties, providing more choice and flexibility to more than 530,000 residents, or 93% of the state's Medicare-eligible population, beginning Jan. 1, 2023.

11:02 EDT Macy's says accelerating growth of off-mall, small-format stores - Macy's announced that, as part of its Polaris strategy, the company will open four new off-mall, small-format stores this fall. The locations will include Market by Macy's, a smaller store that offers customers more to love with its curated assortment of the latest fashion trends, as well as the first-ever dual Market by Macy's and Macy's Backstage off-price location. "As a key pillar of Polaris, the company is focused on repositioning its physical store footprint to better serve its customers and effectively support omnichannel market sales growth. Off-mall, small formats play several roles in the company's Polaris strategy by either expanding its presence in a current market, maintaining market presence by replacing underperforming locations or entering new markets where Macy's doesn't have a presence. As part of Macy's ongoing assessment of its store portfolio, it has decided to close the Macy's Chesterfield location and will replace it with the new Market by Macy's near Chesterfield Commons," the company stated. "During the 2021 calendar year, four new stores were introduced to the public; Presidential Markets and South Point in the Atlanta metro area, and WestBend and Highlands at Flower Mound in the Dallas-Fort Worth area. By the end of 2022, Macy's plans to expand Market by Macy's to eight total locations," the company added.

11:01 EDT Parker-Hannifin teams with Eviation on development of electric commuter aircraft - Parker Aerospace, a business segment of Parker Hannifin Corporation, announced a partnership to further the development of electric flight. Eviation Aircraft has engaged Parker Aerospace to develop six technology system packages for Alice, the first-of-its-kind all-electric commuter aircraft, the company said in a statement. The two companies are now entering the design phase for the production and certification phase of Alice.

10:43 EDT Capri Holdings sees forex headwinds of $300M in FY23

10:32 EDT Precipio to distribute HemeScreen through Fisher Healthcare channel - Precipio (PRPO) announced that it has entered into an agreement with Fisher Healthcare, a part of Thermo Fisher Scientific (TMO) to distribute its proprietary HemeScreen assays to its customers.

10:21 EDT Unilever Food Solutions U.S. recalls Knorr Professional Soup du Jour soup mix - Unilever Food Solutions in the United States is recalling approximately 553 cases of Knorr Professional Soup du Jour Red Thai Style Curry Chicken with Rice Soup Mix because the product contains milk, which is not listed as an ingredient on the label. Persons who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume this product. The products bear establishment number "P-44055" inside the USDA mark of inspection. The products were produced on January 19, 2022 and distributed nationally to professional food service distributors and operators between March 15, 2022 and July 12, 2022. A limited quantity of products were sold directly to consumers. No other Unilever or Knorr products are affected by this recall. To date, the company has not received any reports of consumer complaints or allergic reactions associated with this product. Anyone concerned about an allergic reaction should contact a healthcare provider.

10:18 EDT Capri Holdings up 2% as revenue targets discussed during investor day - Shares of Capri are up 91c, or 2%, to $47.20 as the company discusses its revenue targets and other guidance at its investor day meeting.

10:11 EDT JE Cleantech Holdings Ltd trading resumes

10:06 EDT JE Cleantech Holdings Ltd trading halted, volatility trading pause

10:00 EDT AMTD Digital falls -6.7% - AMTD Digital is down -6.7%, or -$1.66 to $23.22.

10:00 EDT Silvergate Capital rises 8.2% - Silvergate Capital is up 8.2%, or $6.50 to $86.10.

10:00 EDT WeWork rises 8.5% - WeWork is up 8.5%, or 45c to $5.71.

09:51 EDT Wipro sees Q3 IT Services revenue $2.817B-$2.872B

09:47 EDT Belite Bio Inc (ADR) trading halted, volatility trading pause

09:47 EDT AMTD Digital falls -12.1% - AMTD Digital is down -12.1%, or -$3.00 to $21.88.

09:47 EDT ICW Strategic Income Fund rises 4.5% - ICW Strategic Income Fund is up 4.5%, or 22c to $5.13.

09:47 EDT Silvergate Capital rises 5.6% - Silvergate Capital is up 5.6%, or $4.43 to $84.03.

09:40 EDT Take-Two's Zynga says 'Star Wars: Hunters' release delayed - The Zynga Star Wars account issued an update on "Star Wars: Hunters," stating in part: "We are working tirelessly to achieve our vision for Star Wars: Hunters. Our ambition is to create a competitive battle arena game that will entertain for years to come. To ensure we meet the high expectations we are setting for fans globally and ourselves as developers, we have made the decision to delay the worldwide launch of Star Wars: Hunters." The game will now launch in 2023 on Nintendo Switch, iOS, and Android devices, the tweet stated. Reference Link

09:37 EDT Oncopeptides announces FDA public advisory meeting of ODAC on Pepaxto - Oncopeptides announces that the US Food and Drug Administration has announced a forthcoming public advisory meeting of the Oncologic Drugs Advisory Committee, on September 22, 2022, to discuss the benefit/risk of Pepaxto. On January 21 Oncopeptides announced that it has rescinded the October 22, 2021, letter requesting a voluntary withdrawal of the New Drug Application of Pepaxto in the US. The decision was based on comprehensive analyses of the heterogenous overall survival data from the phase 3 OCEAN study, a head-to-head comparison with pomalidomide, as well as other relevant clinical trials. Oncopeptides initiated a dialogue with the FDA to review the data. The FDA interaction has been intensified following the recent European Medicines Agency's Committee for Medicinal Products for Human Use unanimous adoption of a positive opinion recommending the European Commission to grant a full marketing authorization approval of Pepaxti in the European Union. The purpose of the now scheduled ODAC meeting is to discuss the general benefit/risk profile of Pepaxto. In 2021, the purpose of the planned ODAC meeting was to have a discussion on next steps for Pepaxto including whether the indication should remain on the market while additional trial are conducted. Consequently, the objective of this meeting is different than the planned ODAC in 2021.

09:33 EDT Great Southern Bancorp trading halted, volatility trading pause

09:32 EDT Abbott sees FY22 organic sales up high single digits - Says Q2 sales impacted by voluntary recall and manufacturing shutdown for certain infant products. Says a lot of uncertainty for everybody in 2023. Says macroenvironment is challenging. Says shipped just as many Covid tests in first six months of this year as all of last year. Says Nutrition has recovered nicely. Says staffing challenges were a factor. Says biggest headwind for device business was China. Comments and guidance taken from Q2 earnings conference call.

09:20 EDT Cosmos Holdings to acquire Cana Laboratories, terms not disclosed - Cosmos Holdings announced that it has entered into a binding letter of intent to acquire Pharmaceutical Laboratories CANA, a Greek pharmaceutical company that manufactures, sells, distributes, and markets original branded products researched and developed by leading global pharmaceutical and healthcare companies. Founded in 1928, Cana has manufactured and distributed a broad range of proprietary pharmaceutical and health related products. Furthermore, it has operated as a trusted partner of multinational pharmaceutical companies as well as some of the largest Fast Moving Consumer Goods companies. In the last decade, Cana Laboratories' activities also ventured into medical devices, representing major medical technology companies. Cana's 54,000 sq. ft owned production facility located in Athens, Greece, is licensed under European Good Manufacturing Practices and certified by EMA to manufacture pharmaceuticals, food supplements, cosmetics, biocides and medical devices. It has a variety of production lines that can produce solids, orals, semi solids and liquids. The company is ISO 9001:2015 certified. Cana's diversified customer base includes public & private hospitals, pharmacies, supermarkets, wholesalers, etc. Furthermore, its proprietary product portfolio includes pharmaceuticals, dermocosmetics, antiseptics, and food supplements, as well as an infant care organic product line, Biobebe.

09:16 EDT Synaptogenix advances dosing of first patient in dose optimization trial - Synaptogenix announced, in preparation for its next phase of Bryostatin clinical development, the dosing of its first patient in the company's open-label dose optimization clinical trial. Synaptogenix's therapeutic lead drug to treat Alzheimer's disease, Bryostatin, recently showed a statistically significant improvement in the treatment group that was not observed in the placebo group in two pilot, placebo-controlled Phase 2 trials. In the current 6-month trial, enrollment is complete and clinical testing is proceeding toward conclusion. The company expects to announce topline data from its National Institutes of Health- sponsored, Phase 2b clinical trial of Bryostatin-1 for patients suffering from advanced and moderately severe AD during the fourth quarter of 2022."While the current dosing has been found to produce clear cognitive improvement over baseline, the Company has planned a dose-ranging study to optimize the extent and duration of benefits. With the encouraging data reported in our recent article, we want to be well positioned to conduct a registration study and to enter the clinic as soon as possible," stated Dr. Daniel Alkon, President and Chief Scientific Officer. Alan Tuchman M.D., the company's CEO, stated, "We continue to believe Bryostatin is uniquely positioned to target synaptic loss and are looking forward to announcing a read out of our Phase 2 topline data later this year."

09:10 EDT Antelope Enterprise Holdings regains Nasdaq compliance - Antelope Enterprise Holdings announced that on July 19, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market confirming the company has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). The company regained compliance with Nasdaq's requirements when the closing bid price for the company's common stock was at or above $1.00 for 10 consecutive business days and the matter is now closed.

09:09 EDT ACV Auctions announces the launch of its Smart Acquisition Manager - ACV announced the launch of ACV's Smart Acquisition Manager, S.A.M., which delivers two new innovative ways to engage with ACV's marketplace. ACV's S.A.M. offers a buying API to drive a programmatic buying user experience. ACV is making its 20-minute digital auction more powerful by introducing these solutions that allow dealers to set-up proxy bids via an AI-powered buying agent to make data-driven decisions. These proxies will bid on and buy cars within the ACV Marketplace entirely based on the dealer's pre-set criteria. ACV's S.A.M. enables dealers to customize their automatic buying preferences down to minute-level vehicle details. Dealers can use S.A.M. to build highly customized rules that will not only identify vehicle specifications and price ranges, but could, for example, also include preferences for vehicle condition based on ACV's leading inspection reports. "Since our inception, ACV's mission has been to bring trust, transparency and efficiency to the car buying process," said ACV CEO George Chamoun. "One of the most common pieces of feedback we get from dealers is that they need vehicles, and they don't have enough time to manage all the traditional inventory sources. We saw an opportunity to make the inventory buying process even more efficient and can't wait for our customers to leverage S.A.M. and earn back hours of precious time."

09:08 EDT Natures Sunshine Products: U.S. manufacturing facility converts to 100% solar - Nature's Sunshine Products announced that its US manufacturing facility has converted to 100% solar energy to power its operations. In its inaugural environmental, social and governance report Nature's Sunshine set a goal to transition its owned manufacturing facilities to 100% renewable energy sources by 2023.

09:07 EDT Senmiao Technology reports ride-hailing platform metrics for June - Senmiao Technology announced the operating metrics for its proprietary online ride-hailing platform for the month of June. In June, Senmiao and its affiliates reported over 0.92M total completed orders, a 1.7% decrease from over 0.93M total orders completed in May.

09:06 EDT Portage Biotech acquires minority interest of iNKT agonist platform - Portage Biotech announced that the Company has acquired the outstanding ownership interest of its invariant natural killer T cell, iNKT agonist, platform and now fully owns the worldwide rights to its small molecule iNKT agonists, including lead programs PORT-2 and PORT-3. The platform was acquired through Portage's iOx Therapeutics subsidiary from the founding equity holders in exchange for 1,070,000 ordinary shares of Portage. Additionally, a payment of $25,000,000 in Portage ordinary shares or cash would be triggered upon the achievement of a certain clinical milestone in the PORT-2 or PORT-3 programs. Both PORT-2 and PORT-3 are potent approaches to priming and boosting an immune response in solid tumors with potential to address unmet need in cancer treatment. PORT-2 is a liposomal formulation of an iNKT agonist, IMM60, while PORT-3 is a nanoparticle coformulation of Portage's iNKT agonist packaged with an antigen to establish immune priming and boosting. Leadership at Portage initially founded iOx Therapeutics in February 2015 based on the preclinical potential of iNKT agonist technology, which has been shown to inhibit the growth of tumors in multiple cancer types. Both PORT-2 and PORT-3 are in clinical trials in melanoma and non-small cell lung cancer and NY-ESO-1 positive solid tumors. The Company expects preliminary data from these programs by the end of 2022 and early 2023, respectively. The decision to commit full ownership to the iNKT platform demonstrates the Company's commitment to the ongoing PORT-2 and PORT-3 programs and the iNKT platform as a whole. "This transaction demonstrates our belief in the potential of iNKTs to drive an innate and adaptive immune response while correcting the suppressive tumor microenvironment," said Dr. Ian Walters, Chief Executive Officer of Portage Biotech. "With development of both PORT-2 and PORT-3 progressing and preliminary efficacy data expected later this year, we believe the time is right for us to acquire full ownership of these promising assets. With our recent acquisition of Tarus Therapeutics, Portage now has two fully owned broad immunotherapy platforms with four clinical-stage assets."

09:04 EDT MICT, Inc. to file Q1 results ahead of close of business on July 22 - MICT announces its intention to file its Form 10-Q outlining first quarter 2022 financial results by close of business on Friday, July 22, 2022. Darren Mercer, MICT's CEO comments, "Following the unavoidable delays that arose due to the extremely strict COVID-19 lockdown protocols imposed throughout large parts of China, and now that our 2021 year-end results have been reported, we are pleased to report that we and our auditors have completed our first quarter 10-Q report and expect to file it by end of business day on Friday, July 22, 2022. With this filing complete, we will be current with our SEC quarterly filings. We thank our employees and auditors for their dedication and hard work, and our stockholders for their continued support and patience, as we manage through these unavoidable circumstances. With lockdowns in China beginning to ease, we expect future periods to be completed in a timely manner. We look forward to sharing our results by Friday."

09:04 EDT Humana to hire 300 seasonal employees - Humana announced it is looking to hire about 300 seasonal enrollment representatives for nationwide work-from-home positions. Humana's Medicare enrollment representatives respond to inquiries from current and prospective members seeking to enroll in a 2023 Medicare Advantage or Prescription Drug Plan. They also review and process member applications. These seasonal employees will serve for six months or less through the Medicare Advantage and Prescription Drug Plan open enrollment window, which runs October 15 through December 7.

09:02 EDT Boeing, Azerbaijan Airlines sign MoU for four additional 787-8s - Boeing and Azerbaijan Airlines signed a Memorandum of Understanding for four additional fuel-efficient 787-8s at the Farnborough International Airshow. The Azerbaijan flag-carrier currently operates two 787-8s, with this announcement the airline intends to grow its Dreamliner fleet to 10 by 2030, enabling it to open new routes across Central Asia.

08:56 EDT Sabre's Radixx portfolio selected by AirJapan to support business model - Sabre Corporation announced a new agreement between Sabre company Radixx and All Nippon Airways' new airline brand, AirJapan. The carrier will use the full suite of Radixx products including the Radixx Res passenger services system and mobile check-in capabilities to support its aim of meeting emerging trends for international travel, the companies said.

08:40 EDT Quantum Computing solves 3,854-variable optimization problem - Quantum Computing announced that it has solved an optimization problem with over 3,800 variables in six minutes, delivering a superior and feasible solution. The Company achieved this landmark by applying a new quantum hardware technology called Entropy Quantum Computing to the BMW Vehicle Sensor Placement challenge, a complex problem consisting of 3,854 variables and over 500 constraints. In comparison, today's Noisy Intermediate Scale Quantum computers can process approximately 127 variables for a problem of similar complexity.

08:36 EDT FaZe Clan completes combination with B. Riley Principal 150 Merger - FaZe Clan announced that on July 19, it completed its business combination with B. Riley Principal 150 Merger Corp. (BRPM), a special purpose acquisition company sponsored by an affiliate of B. Riley Financial (RILY). In connection with the closing of the Business Combination, the combined company has been renamed "FaZe Holdings Inc." Shares of FaZe's common stock and warrants commence trading on Wednesday July 20, on NASDAQ under the new ticker symbols "FAZE" and "FAZEW", respectively.

08:36 EDT E-Home updates business development of carbon neutral, green initiative - E-Home Household Service Holdings announced the Company has signed contract with Fujian Fusheng Property Management to provide domestic garbage sorting and dumping services for neighborhoods under Fusheng's management that incorporates waste collection practices to help reduce household carbon emissions. E-Home's garbage collection services are designed to facilitate recycling and composting, as well as incentivizing energy-from-waste facilities, which would help reduce household reliance on landfills and lower green-house-gas emissions. The Company also signed similar service contracts with Shanghai Fanying Environment Engineering, Fuzhou Company to provide environmentally sustainable garbage sorting for three properties under Fanying Fuzhou's management. The contracts have been awarded following E-Home's announcement to launch specialized waste classification, energy saving and emission reduction household Services on July 14. Wenshan Xie, Chairman and CEO of E-Home, commented: "We are thrilled to announce business development of our carbon neutral initiative only a week after we launched this new service, which shows our determination to help manage trash creation and contribute to recycling and composting efforts nationwide. Next, we'll continue expand our efforts to more waste management options, including energy-from-waste facilities that provide a means for waste disposal while also generating clean electricity. We believe such alternative 'green' household cleaning services would both help combat climate change and achieve sustainable, strong growth for our business as a whole."

08:34 EDT Streamline Health signs new contract for Streamline Health eValuator - Streamline Health Solutions announced it has signed a contract with a 50-hospital health system in the Southwest. The system will use eValuator's automated pre- and post-bill coding analysis technology to help improve revenue integrity and financial performance from their inpatient, outpatient and professional fee services. "Our newest client is a nationally recognized leader in care delivery, and we're honored to partner with them in optimizing revenue integrity and financial performance prior to billing," stated Tee Green, President and Chief Executive Officer, Streamline Health Solutions. "Along with inpatient and outpatient coverage, our recent addition of Pro-Fee functionality means eValuator will help the organization proactively improve compliant revenue capture across the enterprise."

08:33 EDT Schmitt Industries announces non-binding term sheet with Proton Green - Schmitt Industries announced that it entered into a non-binding term sheet which contemplates the reverse merger with Proton Green, LLC and the spin-off of Schmitt's Ample Hills business. Under the merger agreement, Proton Green would become a wholly owned subsidiary of Schmitt. The Company would be renamed "Proton Green Corporation" and the common stock would continue to trade on the Nasdaq under a new symbol. The transaction would include a Spin-Off of Schmitt's Ample Hills business to pre-Merger shareholders of Schmitt's common stock. The Term Sheet contemplates the execution of a merger agreement whereby the security holders of Proton Green would receive Schmitt securities in the Merger, in exchange for securities held in Proton Green. In addition, the Term Sheet contemplates the Spin-Off of Schmitt's Ample Hills business to the pre-Merger shareholders of Schmitt's common stock subsequent to the closing of the anticipated Merger. The contemplated business combination would give Schmitt investors exposure to the promising helium, hydrogen and clean energy industries in which Proton Green has established footholds and operating assets, while allowing Proton Green to fund its strategic initiatives through the public capital markets. Based on the initial valuations, Schmitt anticipates that the security holders of Proton Green and Schmitt would hold approximately 95% and 5%, respectively, of the combined company. Such ratio could be subject to proportional dilution for any anticipated financing in connection with the Closing, which dilution could be impacted by the Company's intent to transfer $10 million to its Ample Hills business in connection with the Spin-Off. Assuming Schmitt and Proton Green enter into the Merger Agreement, the parties will look to seek shareholder approval from Schmitt's shareholders in the fourth calendar quarter of 2022, subject to SEC staff review of the proxy statement to be filed by Schmitt for the proposed transaction.

08:32 EDT Teck Resources, PolyMet Mining form copper nickel projects joint venture - Teck Resources (TECK) announced an agreement with PolyMet Mining Corp. (PLM) to form a 50:50 joint venture to advance PolyMet Mining Inc's NorthMet Project and Teck's Mesaba mineral deposit. The joint venture will be named NewRange Copper Nickel. Glencore plc (GLNCY) will retain its majority equity interest in PolyMet and provide financial support for its share of the funding commitment to the joint venture. Closing of the transaction will be subject to customary closing conditions, including receipt of all required regulatory approvals.

08:29 EDT Partner announces resignation of Tamir Amar as deputy CEO, CFO - Partner Communications reports that Tamir Amar, Deputy CEO, Chief Financial Officer & VP Fiber-Optics, has notified the CEO of his resignation from the company. The effective date of Tamir Amar's resignation as the company's Deputy CEO, Chief Financial Officer & VP Fiber-Optics has not yet been determined.

08:26 EDT Cuentas issues shareholder report with company updates - Cuentas has issued a shareholder report with three major company updates: Cuentas, Inc. generated the largest revenue growth for e-commerce and digital content in company history following its purchase of 20% of the assets of SDI Black 011, a leader in the digital product and service distribution industry, in order to reach more bodegas and retailers. Cuentas has up to 90 days from contract to acquire the remaining 80% of SDI Black 011 assets. Cuentas, Inc. is in final negotiations to sign with a Texas-based issuing bank, opening a new business segment that would enable Cuentas users to acquire a secured credit card using Cuentas' mobile app and ecosystem. Cuentas, Inc. is in final negotiations with a cutting edge technology company to offer merchant services, cash reloads and state of the art POS devices to Cuentas' current distribution channels. The POS solution is currently installed and active in over 10,000 locations in the US. Augmenting these existing 10,000 retail locations with Cuentas' 31,000 bodegas will diversify and expand Cuentas' retail distribution network significantly. "These are three remarkable developments for our company, customers, and investors," says Arik Maimon, co-founder and Executive Chairman of Cuentas. "Such a massive leap in revenue is proof of the functionality of our ecosystem and the growing demand for Cuentas' services." He continued, "Our partnership with the Texas issuing bank would allow thousands of underbanked consumers to build credit, while our integration with the POS system will enable us to offer our products and services and potentially offer fast cash reloads on the Cuentas debit card through up to 31,000 bodegas. We are working diligently to maintain this positive trend in the months to come."

08:24 EDT Polymet Mining trading halted, news pending

08:21 EDT Otonomo Technologies updates Otonomo app on Salesforce AppExchange - Otonomo Technologiesannounced it has updated the Otonomo App on Salesforce AppExchange, providing customers new ways to unlock access to accurate mobility data-for single vehicles as well as entire fleets- Salesforce Sales Cloud and Service Cloud. The latest version will utilize multi-faceted functionality that allows customers to build upon workflows, trigger specific actions, access distance and dispatch data, execute geofencing, and driver safety capabilities. Built on the Salesforce Platform, the Otonomo App is currently available on AppExchange.

08:19 EDT Mason Graphite closes transactions with Nouveau Monde - Mason Graphite announced the initial closing of the previously announced transactions contemplated under the investment agreement dated May 15, 2022 between the Company and Nouveau Monde Graphite. Pursuant to the Investment Agreement, Mason Graphite has entered into an option and joint venture agreement with Nouveau Monde. Concurrently with the execution of the OJV Agreement, Mason Graphite and Nouveau Monde have completed the private placement of 5.0 million common shares of the Company to Nouveau Monde at a price of $0.50 per Inital Share for gross proceeds to the Company of $2.5 million. The Company intends to use the net proceeds from the sale of the Initial Shares to fund agreed expenses on the Lac Gueret property pursuant to the OJV Agreement. The Initial Shares will be subject to a four-month hold period pursuant to applicable securities laws.

08:18 EDT SeaStar Medical submits HDE application to FDA for SCD in children - SeaStar Medical and LMF Acquisition Opportunities announced SeaStar Medical has submitted its application to the U.S. Food and Drug Administration for Humanitarian Device Exemption for use of the Selective Cytopheretic Device for critically-ill children with acute kidney injury. The FDA informed SeaStar Medical that it has accepted the application and will begin its review. The SCD is an extracorporeal device designed to be used as an adjunct therapy with continuous renal replacement therapy to improve the outcomes of pediatric patients with AKI. The HDE application submission to the FDA is based on findings from SeaStar Medical's Pilot Study of pediatric patients with AKI. This study demonstrated that the SCD was safe for use in pediatric patients.

08:16 EDT IonQ announces expansion with first European and Israeli entities - IonQ announced the creation of its first European and Israeli entities in support of growing regional investments in quantum computing. The German and Israeli-based entities, IonQ GmBH and IonQ Israel LTD, will provide IonQ's industry-leading quantum systems to various European companies, states, and governments. "With our new German and Israeli presence, we believe IonQ is well positioned to support global commercial partners as they take advantage of our world-class, trapped-ion systems for a multitude of industries," said Peter Chapman, President and CEO, IonQ. "By incorporating in Germany and Israel, we are taking steps to truly embed ourselves within the European and Israeli tech ecosystem, democratizing access to quantum and creating new pathways to pursue curiosity. We are being clear - IonQ has a long-term commitment to the regions." To lead the new German and Israeli entities, IonQ has hired Noam Zakay as its new Managing Director, IonQ GmBH. Noam joins IonQ after working as a Business Development Executive at IBM for nearly three decades, where he most recently served as the Program Director of IBM Quantum Europe. Noam is based out of Haifa, Israel and will oversee business development and sales throughout the region.

08:13 EDT Freshworks announces Summer '22 Product Launch - Freshworks announced its Summer '22 Product Launch - a collection of customer and employee engagement innovations to power smarter conversations everywhere. Now available in Freshworks Summer '22 Product Launch - FreshchatAI bot-assisted conversational messaging joins Freshmarketer and Freshsales on the Freshworks' unified customer record architecture. This collection improves customer engagement by unifying messaging channels on a single platform for more intelligent and more productive interactions between customers and employees.

08:13 EDT BMO Financial Group to acquire Radicle Group, terms not disclosed - BMO Financial Group announced that it has entered into a definitive agreement to acquire Radicle Group, a Calgary-based company in sustainability advisory services and solutions, and technology-driven emissions measurement and management. The transaction is subject to receipt of required regulatory approvals and other customary conditions. It is expected to close by the end of calendar 2022. Terms were not disclosed.

08:12 EDT Alvotech initiates pharmacokinetic study for AVT03 - Alvotech announced the initiation of a pharmacokinetic study for AVT03, a biosimilar candidate to Prolia and Xgeva. The clinical study will assess the pharmacokinetics, safety and tolerability of AVT03 compared to Prolia in healthy adult male subjects.

08:10 EDT Inter Parfums in deal with G-III Apparel as licensee for Donna Karan and DKNY - Inter Parfums (IPAR) announced that it has closed its agreement with G-III Apparel Group (GIII) to become the exclusive worldwide licensee for the Donna Karan and DKNY fragrance brands as of July 1. Jean Madar, Chairman and Chief Executive Officer of Inter Parfums, Inc., stated, "We are excited to complete this transaction with these established and valuable fragrance brands, Donna Karan and DKNY... Morris Goldfarb, Chairman and CEO of G-III Apparel Group, Ltd., parent of the Donna Karan and DKNY brands, stated, "We are proud of our brands' best-in-class fragrances that have extended their reach beyond fashion by connecting to a broader range of consumers globally. Inter Parfums' exceptional capability to develop fragrances and enhance portfolios with their significant worldwide distribution will work hand-in-hand with us to position Donna Karan and DKNY for further global expansion. We're looking forward to our partnership with Inter Parfums to grow these businesses together."

08:09 EDT Verb Technology to host Shopfest livestream shopping event - Verb Technology Company will host Shopfest, a 3-day livestream shopping event taking place July 26, 27 and 28 to mark the launch of MARKET, VERB's new 24/7 social shopping and livestream commerce platform where shoppers can explore hundreds of livestream shoppable stores, with more added every day.

08:07 EDT Sensus Healthcare announces expansion of relationship with CSU - Sensus Healthcare announces the expansion of its relationship with Colorado State University, CSU, College of Veterinary Medicine and Biomedical Studies with the acquisition of a second SRT-100 system by CSU. Studies at CSU's new Johnson Family Equine Hospital in Fort Collins are expected to be conducted primarily in ophthalmic indications. "We are excited to continue our relationship with Sensus Healthcare and look forward to expanding our work to include horses," said Kathryn Wotman, Assistant Professor at CSU. Commenting on the agreement, John Heinrich, Ph.D., member of the Sensus Healthcare board of directors and the key relationship contact with CSU, added, "We are delighted to expand our relationship with the Colorado State School of Veterinary Medicine with a second SRT system. The recent dedication of the Johnson Family Equine Hospital provides an ideal environment for the cooperative implementation and validation of equine oncological applications of our technology."

08:06 EDT Stran & Company launches expanded sales, marketing strategy - Stran & Company announced the launch of an expanded sales and marketing strategy. Stran is establishing a dedicated lead generation team comprised of experienced industry veterans, as well as increasing its digital marketing to capitalize on the demand for the Company's products and services.

08:05 EDT Nutrien to acquire Casa do Adubo, terms undisclosed - Nutrien announced that it has entered into an agreement to acquire Brazilian company Casa do Adubo. The acquisition includes 39 retail locations, under the brand Casa do Adubo, and 10 distribution centers, under the brand Agrodistribuidor Casal, in the states of Acre, Bahia, Espirito Santo, Maranhao, Mato Grosso, Minas Gerais, Para, Rio de Janeiro, Rondonia, Sao Paulo and Tocantins. The transaction supports Nutrien's Retail growth strategy in Brazil. The acquisition of Casa do Adubo is expected to result in additional run-rate sales of approximately $400M, increasing total Nutrien Ag Solutions annual sales in Latin America to approximately $2.2B. Upon completion of the acquisition of Casa do Adubo, Nutrien expects to surpass its stated target of $100M of adjusted EBITDA in Brazil by 2023. The transaction is pending approval from the Administrative Council for Economic Defense, or CADE, in Brazil. Subject to approval and completion of the acquisition, Nutrien will have 180 commercial units in Latin America, including customer-facing retail branches and experience centers, five industrial plants and four fertilizer blenders. In addition, Nutrien will have more than 3,500 employees in the region, including more than 700 crop consultants serving growers in Argentina, Brazil, Chile, and Uruguay.

08:05 EDT ProKidney appoints Kerry Cooper as SVP, medical affairs - ProKidney Corp. (PROK) announces the appointment of nephrologist Kerry Cooper, M.D. as Senior Vice President of Medical Affairs. Dr. Cooper, who will report to CMO Libbie McKenzie, joins ProKidney from AstraZeneca (AZN), where he was Vice President, U.S. Medical Affairs Renal Division.

08:04 EDT Etsy names Kruti Patel Goyal CEO of Depop, Nick Daniel CPO of Etsy - Etsy announced that Kruti Patel Goyal, currently Etsy's Chief Product Officer, has been named CEO of its subsidiary Depop, a global fashion resale marketplace, effective September 12, 2022. Maria Raga, Depop's current CEO, has resigned to pursue personal ventures, but will remain with Depop in an advisory capacity until September 30, 2022 to facilitate a smooth transition. With Kruti's transition to her new role, Etsy has promoted Nick Daniel, Vice President of Product Management, to Chief Product Officer. Etsy, Inc. Chief Executive Officer Josh Silverman commented, "Depop is a highly-relevant and authentic re-commerce brand that we believe is still early in its growth lifecycle. I have no doubt Kruti is the right leader for Depop's next chapter as we focus on nurturing its passionate community and improving the customer experience. She has guided Etsy through periods of significant transformation, with a proven track record of motivating teams to deliver results and advance our mission." Both Kruti and Nick will report to Etsy CEO Josh Silverman, and Nick will join Etsy's executive team.

08:04 EDT Grom Educational Services rolls out updated Digital Citizenship Licensing course - Grom Educational Services is rolling out an updated Digital Citizenship Licensing course available for K-12 school customers nationwide who utilize the company's web filter solution as the new academic year commences.

08:03 EDT FactSet launches FactSet for CRM on Salesforce AppExchange - FactSet announced it has launched FactSet for CRM on Salesforce AppExchange, empowering clients to enhance pipeline visibility by enabling users to monitor news, company events, and other market intelligence notifications on current and potential clients. In addition to the FactSet for CRM managed application, FactSet can deliver data directly into clients' instances of Salesforce via data feeds and APIs.

08:02 EDT PTC Therapeutics says Upstaza granted marketing authorization by EC - PTC Therapeutics announced that Upstaza was granted marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase deficiency and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older. The marketing authorization is applicable to all 27 European Union member states, as well as Iceland, Norway and Liechtenstein.

07:40 EDT Australis Capital completes submission to City of Millville, New Jersey - Australis Capital announced that the Company continues to execute on its entry into the New Jersey adult use market. Two key conditions to graduate from provisional to full adult use state license are for the Company to secure appropriate building & land, as well as municipal approval for the establishment of a cannabis business on the designated premises. First condition: The Company has entered into an agreement for the lease of 105,000 square feet of space for a cannabis grow facility in the municipality of Millville, NJ. Under the regulations, the cultivation license allows for a facility with a maximum canopy area of 50,000 sq ft. The licenses will enable the Company to introduce its award-winning brands to the New Jersey market. Effecting the lease is contingent upon the Company being awarded its full license, as well as meeting all municipal and state requirements. Second Condition: The Company is also pleased to announce that it has completed the submission of its application to the City of Millville for municipal approval for the establishment of a cannabis operation at the leased premises. Per its earlier release, the Company intends to construct an Achieve Series facility, which is an all-inclusive indoor facility with the industry's most efficient cannabis-proven LED lighting. The Achieve series was launched in 2021 by ALPS, the Company's majority owned subsidiary. ALPS is a leader in controlled environment agriculture, facility design, delivery, commissioning and post start-up services. The planned facility features a mother room, clone room, veg room, and flower rooms capable of producing 43,000+ pounds of dry flower a year. The Achieve series takes growing to another level while saving on energy costs. The facility is designed with efficiency in mind through a sophisticated nutrient delivery system combined with a high level of automation. This facility will feature an automated benching system for the highest possible efficiency in logistics, benefitting transplant and harvesting greatly. Multiple SKUs can easily be manufactured as the facility includes ample space for dedicated manufacturing. Cultivation and manufacturing systems will be GMP compliant and will address state and municipal safety requirements.

07:38 EDT H World says Q2 RevPAR only recovered to 69% of 2019 level - The company said, "For our Legacy-Huazhu business, the large-scale outbreak of Omicron variant in China since early-March 2022 led to massive lockdown in various cities and sharp decline in the demand for both business and leisure travel. As a result, our RevPAR in Q2 2022 only recovered to 69% of the 2019 level. Breaking down into each month, April and May 2022 were the hardest-hit with RevPAR only having recovered to 53% and 65% of the 2019 levels respectively. However, RevPAR recovery improved in June 2022 to 86% of the 2019 level due to gradual lift of lockdown since late May 2022. In addition, if we consider the impacts of requisitioned hotels, our RevPAR recovery in Q2 2022 would have been 75% of the 2019 level. Steigenberger Hotels AG and its subsidiaries have seen an accelerating RevPAR recovery in Q2 2022. While RevPAR in March 2022 was 35% lower than the 2019 level, June 2022 RevPAR was only 1% behind that of 2019. However, against the background of surging inflation in Europe and the resulting substantial increase in costs as well as uncertainties about the future development of COVID-19 and energy supplies, DH has been focusing on cash flow improvement measures. As a consequence, DH will continue to focus on efficiency improvements, re-negotiation of lease contracts, and personnel cost optimization."

07:36 EDT nCino's SimpleNexus announces OSB Community implemented Nexus Closing - SimpleNexus, an nCino (NCNO) company, announced that OSB Community Bank, a subsidiary of Ottawa Bancorp, has implemented SimpleNexus' Nexus Closing to facilitate hybrid closings. The bank will leverage Nexus Closing alongside Nexus Engagement and Nexus Origination- tools the bank has used for six years - to facilitate a 'from anywhere' borrower experience from application to closing. Nexus Engagement helps lenders and real estate agents develop relationships with early-stage homebuyers through tools such as integrated home search, instant chat and payment calculators. Nexus Origination is a comprehensive point of sale platform that enables borrowers to fill out loan applications, eSign documents, check loan status updates and pay mortgage-related charges through a feature called Nexus Pay. Nexus Closing supports all types of mortgage closings, from traditional to hybrid to full eClosings. The entire SimpleNexus suite can be accessed by borrowers, lenders and other authorized stakeholders from anywhere through a single, sign-on portal.

07:34 EDT Abbott: FY22 guidance includes projected COVID-19 testing-related sales of $6.1B - 2022 guidance includes projected COVID-19 testing-related sales of $6.1B, which includes sales of $5.6B through June 2022 and projected sales of $500M over the next few months.

07:33 EDT SPS Commerce acquires GCommerce for $45M in cash - SPS Commerce announced the acquisition of GCommerce. "We are excited about the acquisition of GCommerce, a software solution provider known for its expertise in the automotive aftermarket industry," said Archie Black, CEO of SPS Commerce. "We are pleased to welcome GCommerce employees and customers to the SPS Commerce community, and I am looking forward to capitalizing on our joint passion for innovation and focus on excellent customer experience." Under the terms of the agreement and plan of merger, SPS Commerce acquired GCommerce for approximately $45 million in cash. For the third quarter of 2022, SPS Commerce anticipates the acquisition will add approximately $1 million of revenue and expects Adjusted EBITDA to be negatively impacted by approximately $300,000. For fiscal year 2022, the Company expects the acquisition will add approximately $2.5 million in revenue and expects Adjusted EBITDA to be negatively impacted by approximately $300,000. The Company expects the acquisition to contribute approximately $7 million in revenue and approximately $2.5 million in Adjusted EBITDA in fiscal year 2023.

07:31 EDT Abeona Therapeutics regains complains with Nasdaq listing requirement - Abeona Therapeutics announced that it received notice from The Nasdaq Stock Market on July 19, 2022 informing Abeona that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. In order to regain compliance with the Rule, the Company's common stock was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days. That requirement was met on July 18, 2022.

07:27 EDT Natural Gas Services announce commitment to electrification of compression fleet - Natural Gas Services Group announced, as a component of its ongoing commitment to environmental stewardship and to become a leader in energy transition efforts, a program to convert up to 100 compressor packages from combustible gas engines to electric motors over the course of the next three-to-six months. The initial conversions will focus on repurposing existing compression packages in the 200-250 horsepower range where the Company believes there is significant demand for electric units. The electrification of a current combustion engine compressor is expected to cost approximately $45,000 - $60,000 and take up to one month to complete. Funding for the conversions will come from cash on hand. The Company will provide an update on the progress of the electrification program on its second quarter earnings call to be scheduled for mid-August.

07:22 EDT Aclarion launches Economic Value Analysis study for nociscan - Aclarion announced the launch of the Economic Value Analysis of Low back pain study; a rigorous healthcare economic study to assess the impact of the Nociscan solution on the cost of care for patients suffering from chronic low back pain. The University of California at San Francisco and the Center for Disruptive Musculoskeletal Innovations, which is funded by the National Science Foundation, is conducting the study using outcomes data from previously published clinical studies. Initial findings from the EVAL study are expected to be released in Q4 2022. The Company expects results of this study to provide strong economic support for the utilization of Nociscan in the assessment of CLBP and to use this data to accelerate coverage decisions from insurance companies and self-insured employers.

07:20 EDT Unicycive reports results from market research study with nephrologists - Unicycive Therapeutics announced the results from a primary market research study conducted on behalf of the company by Reason Research, LLC. The study was a discrete-choice model analysis in which 100 US-based nephrologists were presented with various phosphate binder attributes, including efficacy, safety/tolerability, pill burden, composition, and dose form, in a trade-off methodology to determine comparative prescribing preferences for currently available phosphate binders and Renazorb, Unicycive's product under development. Key findings from the research: Nephrologists estimate that they will prescribe Renazorb for a market-leading 34% of their dialysis patients requiring phosphate binder therapy. Nephrologists stated that the greatest unmet need in the treatment of hyperphosphatemia with phosphate binders is Lower pill burden/Better patient compliance; Lower pill burden/Better patient compliance, Greater efficacy, Better tolerability, Less frequent dosing, New MOA, Lower cost.

07:18 EDT Aesthetic Medical enters cooperation agreement - On July 20, 2022, Peak Asia Investment Holdings V Limited and its affiliate, the Company, the Founders, Wanda and Jiechuang entered into a Cooperation Agreement. The Cooperation Agreement provides, among other things, that: ADV shall, with respect to each annual and extraordinary meeting of the Company, be present at such meeting or otherwise cause all ordinary shares and American Depositary Shares beneficially owned by ADV to be counted as present for the purpose of establishing a quorum, and respond to each request by the Company for written consent; vote, or cause to be voted at such meeting, all Covered Shares in favor of the proposed transactions contemplated in the Cooperation Agreement, the adoption of the transaction agreements pertaining to the proposed transactions contemplated in the Cooperation Agreements and any other matters necessary for consummation of the proposed transactions, and against any proposal or transaction that competes with proposed transactions, and any other action that would impede, interfere with, delay, postpone or adversely affect the proposed transactions. ADV has not granted, and shall not grant at any time prior to the Closing, a proxy or power of attorney with respect to any Covered Shares which is inconsistent with ADV's obligations pursuant to the Cooperation Agreement. Upon the Closing, ADV shall, subject to the requisite approvals being obtained and continuing in force, convert the outstanding Principal Amount and the Conversion Catch-up Amount, at a conversion price that is equal to the USD equivalent of RMB4.203 per ordinary share. The Company shall execute and deliver to ADV the warrant for the purchase of shares of the Company to ADV on the date of the Cooperation Agreement. The Warrant shall be effective on and from the Closing and shall be exercisable into ordinary shares of the Company in accordance with the terms thereof. The warrant exercise price shall be equal to the USD equivalent of RMB4.67 per ordinary share and may be settled, subject to the terms and conditions of Warrant, by way of cashless settlement and/or set-off against the Exit Payment. The Warrant shall contain customary registration rights and the Warrant Shares shall be freely transferable on the exercise of the Warrant. The Cooperation Agreement shall come into effect from the date hereof, and each party may terminate the Cooperation Agreement upon the earlier of the following: if the Closing does not occur by the Outside Date; and any of the transaction agreements is terminated. "Outside Date" means December 31, 2022; if all the conditions, other than the satisfaction of the PRC regulatory condition in respect of the proposed transaction (including approvals/registrations/filings required for outward foreign direct investment and antitrust approvals/filings), are satisfied or waived by December 31, 2022, March 31, 2023; or such other date as agreed between the parties to the Cooperation Agreement. Upon the closing of all proposed transactions, the share percentage of AIH held by the Sellers, Wanda, Jiechuang, and ADV would be the number of ordinary shares of the Company held by each of them denominated by the sum of 92,116,947 ordinary shares issued and outstanding as of the date of this 6-K, 36,402,570 newly issued ordinary shares pursuant to the Subscription Agreement, and the ordinary shares issued upon the conversion of ADV's Note at its conversion price as of the Closing. This calculation has not taken into consideration of warrants delivered to Seefar, Wanda, and ADV, the number of which would be determined at the closing of all proposed transactions and may cause further change on the number of total ordinary shares outstanding.

07:15 EDT Aesthetic Medical enters subscription agreement - On July 20, 2022, the Company, the Founders and Hainan Oriental Jiechuang Investment Partnership as the investor entered into a Subscription Agreement. Pursuant to the Subscription Agreement, Jiechuang agrees to subscribe an aggregate of 36,402,570 newly issued ordinary shares of the Company for the total consideration in USD that is equivalent of RMB170 million, representing a subscription price of RMB4.67 per ordinary share. The actual subscription price in terms of the U.S. dollar per ADS is subject to change based on the exchange rate one day prior to the closing date. The Founders entered into the Subscription Agreement as parties to the Agreement and guarantors for the Company. Shenzhen Lafang Investment Management Co., and Shenzhen Venture Capital M&A Fund Management Co., Ltd are the general partners of Jiechuang, where Lafang Investment serves as the executive partner. Shenzhen Capital Group Co.,Ltd. is a limited partner of Jiechuang. The subscription of the Subscription Shares is expected to close during the fourth quarter of 2022 and is subject to customary closing conditions, including but not limited to obtaining approvals for ODI. Nasdaq Rules 5635(d) provides that shareholder approval is required prior to issuance of securities in relation to transactions other than public offerings whereby there is a 20% Issuance at a price that is less than the Minimum Price, as such terms are defined in Nasdaq Rules 5635(d). Under the articles of association of the Company, shareholders approval is required for a Change of Control Event. Pursuant to the Share Purchase Agreement and the Subscription Agreement, we will obtain shareholders' approval for the Share Transfer as well as the issuance of the Subscription Shares prior to the closing of the proposed transactions thereunder.

07:14 EDT Aesthetic Medical enters share purchase agreement - On July 20, 2022, the Company, Dr. Pengwu Zhou and Ms. Wenting Ding, certain existing shareholders of the Company controlled by the Founders and Australia Wanda International Company entered into a Share Purchase Agreement. Pursuant to the Share Purchase Agreement, Seefar Global Holdings, Jubilee Set Investments, and Pengai Hospital Management Corporation agreed to sell and Wanda as the buyer agreed to purchase, an aggregate of 21,321,962 ordinary shares of the Company for the total consideration in USD that is equivalent of RMB100 million, representing a price of RMB4.67 per Sale Share. The Founders entered into the Share Purchase Agreement as parties to the Share Purchase Agreement and guarantors for the Sellers. The Share Transfer is expected to close during the fourth quarter of 2022 and is subject to customary closing conditions, including but not limited to obtaining approvals for outward foreign direct investment.

07:12 EDT Biogen sees utilizing portion of remaining buyback authorization through 2022E - Biogen said it expects to utilize a portion of the remaining share repurchase authorization of $2.3B through the end of 2022.

07:11 EDT React Gaming commences trading on OTCQB Venture Market - React Gaming Group announced that it has qualified to trade on the OTCQB Venture Market in the United States. The Corporation upgraded to the OTCQB from the Pink market.

07:10 EDT Solaris Resources reports assay results from Warintza Project - Solaris Resources reports assay results from a series of holes aimed at growing the Northeast Extension of the 'Indicative Starter Pit' at its Warintza Project in southeastern Ecuador. Highlights: Additional drilling has expanded the Northeast Extension of the 'Indicative Starter Pit recently estimated at 180 Mt at 0.82% CuEq and 107 Mt at 0.73% CuEq within the Warintza Mineral Resource Estimate. This zone is characterized by near surface, high-grade mineralization and remains open for further growth with follow-up and step-out drilling underway. SLS-62 was collared at the northern limit of Warintza Central and drilled northeast into an open volume, returning 168m of 0.68% CuEq from 102m depth within a broader interval of 900m of 0.45% CuEq from surface, expanding on prior drilling further to the east. This hole represents the first follow-up to SLS-48, collared from the same pad but drilled to the south, which returned 100m of 1.64% CuEq from 50m depth within a broader interval of 852m of 0.56% CuEq. SLS-63 was collared at the northeastern limit of the Warintza Central grid approximately 200m to the east and drilled into an open volume to the north-northeast, returning 230m of 1.02% CuEq from 118m depth within a broader interval of 472m of 0.76% CuEq from surface. This hole follows on SLS-57, which was drilled northeast from the same pad, returning 230m of 0.73% CuEq from 56m depth within a broader interval of 926m of 0.61% CuEq from surface and SLS-54, drilled to the south and returning 356m of 0.73% CuEq from 50m depth within a broader interval of 1,093m of 0.56% CuEq from surface. Follow-up drilling is underway and aims to test the Northeast Extension zone further to the north and northeast, with assays expected shortly for SLS-64, representing a follow-up hole from the same pad as SLS-62 and SLS-48. Jorge Fierro, Vice President, Exploration, commented: "Ongoing drilling from existing and newly constructed platforms aims to expand on the Northeast Extension zone, which is one of the key target areas for the expansion of the 'Indicative Starter Pit,' along with higher grade, near surface mineralization being targeted at Warintza East, where results are pending."

07:09 EDT Femasys to host KOL event on FemBloc birth control solution - Femasys announced that, in the wake of the overturn of Roe v. Wade, it will host a key opinion leader event to discuss FemBloc, the Company's proprietary, a medical solution for permanent birth control, on Thursday, July 28, 2022 at 10:30am Eastern Daylight Time. The webinar will feature a presentation from KOL, Paul D. Blumenthal, MD, MPH, Professor of Obstetrics and Gynecology at The Stanford University Medical Center, who will discuss the unmet need for women seeking permanent birth control options. Dr. Blumenthal has a distinguished career in Obstetrics & Gynecology spanning close to 40 years and has conducted advocacy work in Women's Health on a global basis. Femasys' FemBloc, a novel approach to permanent birth control, will be discussed as an important potential medical solution as it pertains to women's contraceptive options and choices, especially given the recent overturning of Roe v. Wade. FemBloc features a proprietary delivery platform, which uses balloon technology designed to precisely deliver a biopolymer to the fallopian tubes to close the tubal lumen leaving no permanent implant behind. This nonsurgical, in-office approach eliminates the risks of incisions, anesthesia, and hormones. Confirmation of procedure success can be achieved after 90 days, which would provide women with a certainty no other option can achieve.

07:06 EDT Origin Materials, Revlon enter carbon negative material joint initiative - Origin Materials (ORGN) and Revlon (REV) announced a joint initiative to develop advanced carbon negative materials for next generation cosmetics packaging. As part of the initiative, Revlon has signed a memorandum of understanding to reserve commercial volumes of Origin PET. The joint initiative's goal is to pursue the rapid development and commercialization of new sustainable materials for cosmetics packaging based on Origin's patented technology platform.

07:06 EDT Marimaca Copper announces further results from infill, drilling campaign - Marimaca Copper announces further results from the 2022 infill and extensional drilling campaign. Results reflect a total of 4,068m across 20 drill holes. The drilling intersected broad zones of near-surface green copper oxide mineralization in 19 of the 20 drill holes. Drilling was focused on infilling the higher-grade central core of the MOD, and the MAMIX depth-extension zone discovered in the 2021 drilling campaign. As with previous results, drilling continues to demonstrate the excellent thickness and continuity of the mineralized column at the Marimaca Oxide Deposit. Sergio Rivera, VP Exploration of Marimaca Copper, commented: "We have now completed the drilling planned to be captured in the 2022 MRE update, which includes all the planned MAMIX and peripheral drill holes targeting resource growth. Results continue to be in-line with our geological interpretation at the MOD, with the excellent grade and vertical continuity of the Marimaca system demonstrated again in this latest batch of results. The 2022 infill campaign has been an important de-risking milestone for Marimaca as our confidence in the ore body continues to improve."

07:05 EDT Skye Bioscience updates Phase 1 timeline - Skye Bioscience has been advised by its contract manufacturer, CMO, of its Phase 1 clinical trial material that a now-resolved cyber-attack on the CMO's computer systems as well as a planned annual maintenance shutdown will result in a delay in completing production of Skye's Phase 1 drug to the beginning of September. Skye now expects to initiate enrollment of its Phase 1 clinical study in Q4 2022, report preliminary topline data in early Q1 2023, and report final data in Q2 2023. Skye's SBI-100 Ophthalmic Emulsion had most recently been scheduled for production and fill in the first week of July. While the CMO has sufficiently recovered from the recent cyber-attack, planned annual facility maintenance could not be rescheduled. The maintenance schedule has been accelerated and will be conducted through August 30. Skye's SBI-100 product is now planned to be produced and filled in the first week of September, with required drug quality testing completed by the first half of October. "The unpredictable events that have detrimentally affected our production schedule have been frustrating, but we are confident in the renewed commitment of our contract manufacturer to produce our clinical trial material and the schedule to start our planned study," said Punit Dhillon, CEO and Chair of Skye. "Securing approval for the Australian Human Research Ethics Committee at the end of June was a vital factor to move our Phase 1 forward. While the delay in the Phase 1 is not a welcomed outcome, we are pleased that we continue to progress on the logistics that move us toward enrollment and dosing of the first cohort of patients.

07:04 EDT Nasdaq sees 2022 non-GAAP tax rate 24%-26% - The company is narrowing its 2022 non-GAAP operating expense guidance to a range of $1,710 to $1,740 million. Nasdaq continues to expect its 2022 non-GAAP tax rate to be in the range of 24% to 26%.

07:02 EDT Bausch + Lomb initiates search for new CEO, reaffirms FY22 guidance - Bausch + Lomb announced Joseph Papa has stepped down as chair of the Board of Directors of the company. The Board has appointed Thomas Ross, Sr., to serve as the chair of the Board. The company also announced that the Board has begun a search for a new CEO. Papa will remain as CEO and as a member of the Board until his successor is appointed. With this announcement, the company is also affirming its full-year guidance range for 2022, which was first announced in its news release on June 8.

07:01 EDT Societal to provide services to support clinical development of drug in Europe - Societal CDMO announced that it has been selected to provide CDMO services to support the ongoing clinical development of a novel drug candidate in Europe. The compound is an oral solid dose anti-viral therapy product approved for the prevention and treatment of human immunodeficiency virus in select countries in Europe and Societal's work is focused on supporting the expansion of the product's indications. Under terms of the new agreement, Societal CDMO will execute appropriate technology transfer activities, followed by cGMP manufacture of clinical trial material to support the initiation and execution of Phase 2 studies of the drug candidate. This work will include production, packaging and labeling of both the active compound and matching placebo for the study. "This is a key new agreement for Societal CDMO as it is a clear demonstration of the company's ability to capitalize on the increasing interest of drug developers in the onshoring and reshoring of contract manufacturing activities to the U.S. from other regions around the globe. We are proud to be trusted by our partner to execute the tech transfer, manufacturing and packaging services that will be necessary for the initiation of its planned Phase 2 study in Europe," said David Enloe, chief executive officer of Societal CDMO. "We continue to be pleased with our progress in leveraging our end-to-end CDMO service offerings to grow our business and expand our client base."

06:48 EDT Spire Global to bolster weather data, forecasting with microwave sounders - Spire Global announced plans to build upon its fully deployed constellation of over 100 multipurpose satellites with satellites carrying microwave sounders to gather atmospheric moisture and temperature measurements. The measurements collected by these instruments will expand the company's data offerings and, when coupled with the weather and Earth intelligence data that Spire currently collects through radio occultation and reflectometry measurements, will further enhance the value and accuracy of its global weather forecasts.

06:34 EDT MarketAxess CEO says 'macro backdrop is now much improved' - Rick McVey, Chairman of the Board and CEO of MarketAxess, commented: "Record levels of market share in the quarter reflect the strides that we have made over the past year in executing our growth strategy, expanding our geographic diversification and establishing a broader global foundation for growth. The macro backdrop is now much improved, with credit spreads and credit spread volatility moving back into more historical ranges, driving increased estimated cost savings for clients through Open Trading, our unique liquidity pool. We believe that our strong growth in trading volume, broad-based market share gains, both year-over-year and sequentially, and increasing momentum in new product areas, including U.S. Treasuries and municipal bonds, are driving our improved performance."

06:32 EDT MarketAxess backs FY22 expense, CapEx guidance - Based on the progression of operating expenses year-to-date, the company is re-confirming its full year 2022 expense guidance range of $385M-$415M and capital expenditure guidance range of $58M-$62M. The company expects the full year effective tax rate to be at the upper-end of the previously stated range of 24%-26%.

06:09 EDT Elevance Health reports Q2 operating cash flow $2.5B - Operating cash flow was approximately $2.5B, or 1.5 times net income in the second quarter of 2022, an increase of $769M as compared to the prior year quarter. The year-on-year increase was driven by the impact of working capital changes, including the timing of certain provider pass-through payments.

06:04 EDT Mercury Systems to provide radar testing systems to Leonardo - Mercury Systems announced it has been selected by Leonardo UK to provide multiple radar test and simulation systems to factory-test Leonardo's innovative E-scan radar. The company will also provide additional systems to support, maintain and prepare deployed aircraft for specific mission profiles using Mercury's flexible programming environment. This contract follows a previous one awarded by Leonardo to Mercury in 2019 to design and manufacture the next generation of processing technology for Leonardo's E-Scan radar being developed in the UK.

06:03 EDT Hillenbrand signs binding offer to acquire Linxis Group - Hillenbrand announced that it has signed a binding offer to acquire Linxis Group from Iberis International S.A R.L, an affiliate of IK Partners, and additional sellers for an enterprise value of approximately EUR 572M. Linxis Group is a global provider of mixing, ingredient automation, and portioning solutions for food and other higher growth end markets. Upon completion of required works council consultations, the parties expect to enter into a definitive purchase agreement, with closing expected to occur before calendar year end, subject to regulatory approvals. Linxis Group serves customers in over 100 countries. With a global footprint and headquarters in Nantes, France, Linxis Group specializes in the design, manufacturing, and service of dosing, kneading, mixing, granulating, drying and coating technologies that are complementary to the equipment and solutions offered under Hillenbrand's Coperion brand. Linxis Group expects calendar year 2022 revenue of approximately EUR 300M with mid-teen EBITDA margins. Upon completion of this transaction, Linxis Group and its over 1,000 global employees operating in ten manufacturing facilities will join its Coperion and Rotex brands as part of Hillenbrand's Advanced Process Solutions, or APS, segment. The APS segment provides highly engineered industrial equipment and systems and aftermarket parts and services for a variety of end markets and applications. Hillenbrand expects to use committed debt financing, cash on hand, and cash available under its revolving credit facility to fund this acquisition.

05:48 EDT Google fined $375M by Russia for allowing 'prohibited' Ukraine news on platforms - Russia fined Google 21.1 billion rubles, or about $375M, on Monday for repeatedly failing to "remove prohibited information," content related to the country's invasion and war in Ukraine. The country's telecommunication watchdog Roskomnadzor cited a court order and said Google, and in particular YouTube, didn't take down content that discredited "the Armed Forces of the Russian Federation." The watchdog's press release also accused Google of not deleting "materials promoting extremism and terrorism" across its platforms. Reference Link

05:26 EDT ICL, PlantArcBio announce development of bio-stimulant technology platform - ICL and PlantArcBio announced the development of a novel bio-stimulant technology platform, which will improve crop yields while having a minimal impact on the environment. The platform successfully uses of RNAi technology to maximize a plant's natural yield increase mechanisms, without any genetic modification, and was the result of a multi-year research collaboration between the two companies. In early-stage canola field trials, the platform has significantly increased seed weight per hectare for canola crops, and ICL and PlantArcBio are planning larger-scale field trials in 2022. These will include testing the new technology platform using both commercial sprayers and standard farming practices. Greenhouse trials for soybeans and rice are already in progress, with early results showing potential.

05:19 EDT Triumph Group, Navsup enter five-year MRO agreement extension - Triumph Group and Navsup have entered into a five-year maintenance, repair and overhaul agreement extension for the C and D variants of the F/A-18 Hornet Airframe Mounted Accessory Drive gearboxes, or AMAD. Designed and manufactured by Triumph Geared Solutions, this advanced and supportable AMAD extends time on wing. The work will be performed at Triumph's gearbox center of excellence in Park City, Utah.

05:14 EDT Expro secures contract for integrated services package in Germany - Expro has secured a contract for its first integrated services package to support a high-profile geothermal project in the Upper Rhine Graben area of SW-Germany. A consortium formed by Ed. Zublin AG and Huisman Geo B.V, drilling and geothermal energy specialists, have commissioned Expro to deliver an integrated well services program for a new geothermal power plant in the Upper Rhine valley. This eight well contract for Germany's largest private developer of geothermal energy plants includes well construction services and a high-rate surface well test system. The contract which began in June has the potential for a long-term extension to follow the eight-well drilling and testing campaign of Deutsche ErdWarme, or DEW, across four power plants that is that covered by the initially contracted work scope. As part of its long-term strategy, Expro plans to continue to invest in transforming its business portfolio and reducing its greenhouse gas emissions. The company has also a stated aim of achieving Net Zero by 2050 with a 50% reduction in carbon intensity by 2030. A member of the International Geothermal Association and the European Geothermal Energy Council, Expro has been supporting geothermal well services projects since 1986 and is recognized for its solutions. This latest contract builds on the company's strategic desire to help customers unlock new sources of cleaner, low-carbon energy and enhance its support of the global geothermal market.

05:09 EDT NXP Semiconductors collaborates with Hon Hai Precision on vehicle programs - NXP Semiconductors (NXPI) announced that it has signed a memorandum of understanding with Hon Hai Technology Group (HNHPF) to jointly develop platforms for a new generation of smart connected vehicles. Hon Hai, or Foxconn, will leverage NXP's portfolio of automotive technologies and its expertise in safety and security. The collaboration builds on the company's initial digital cockpit partnership, based on the NXP i.MX applications processors and NXP Software Defined Radio platform. The primary focus of the expanded collaboration is aimed at Foxconn's efforts in electrical vehicle, or EV, platforms, leveraging NXP's system expertise and electrification portfolio, from NXP S32 processors to analog-front-end, drivers, networking and power products. Another priority is connectivity solutions using the latest NXP S32 domain and zonal controller family for gateways and vehicle networking control, while also advancing secure car access with ultra-wideband, or UWB, and Bluetooth Low Energy, or BLE. A third pillar is safe automated driving augmented by NXP's leading radar solutions. NXP will also offer hardware and software support and will leverage the expertise of its well-rounded third-party ecosystem in the areas of electrification, connectivity and automation.

05:06 EDT Boeing invests $50M in AEI HorizonX - Boeing has committed a $50M investment in AEI HorizonX, a partnership the company established with private equity firm AE Industrial Partners to invest in transformative aerospace technologies. The new funding will anchor AEI HorizonX's second venture fund, which plans to raise $250M to support start-ups in future mobility, space, sustainability, digital enterprise applications, networks and security.